Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Novo Nordisk Inc News

India Prohibits Advertising for GLP-1 Medications Before Patent Expiration | Whalesbook

11 Mar, 2026

#novonordisk #semaglutide #generic #patentexpiration #diabetes #weightlossmedications ... - LinkedIn

11 Mar, 2026

FDA issues warning to Novo Nordisk for not reporting fatalities and negative side effects.

11 Mar, 2026

The 2026 Expiration of GLP-1 Patents: Generic Drugs, International Rivalry, and the $100 Billion Merger and Acquisition Battle

11 Mar, 2026

See More